Insider · CIK 0001989905
Cynthia Lynn Anderson
Files at VTGN (Vistagen Therapeutics, Inc.). First filing -, latest -.
In brief
Cynthia Lynn Anderson files SEC Form 4 as CFO at VTGN (Vistagen Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Cynthia Lynn Anderson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Common Stock | +6,617 | $1.70 | $11k | 12,801 | Jul 1, 2025 |
| Jun 23, 2025 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jun 25, 2025 |
| Dec 31, 2024 | VTGN Vistagen Therapeutics, Inc. | AGrant or award Common Stock | +2,592 | $2.51 | $6,499 | 6,184 | Jan 13, 2025 |
Questions about Cynthia Lynn Anderson
Answered from the filings on this page, as of the latest one.
Is Cynthia Lynn Anderson buying or selling?
Cynthia Lynn Anderson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Cynthia Lynn Anderson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Cynthia Lynn Anderson has 0.
Where does Cynthia Lynn Anderson file Form 4?
Cynthia Lynn Anderson has filed Form 4 at VTGN (Vistagen Therapeutics, Inc.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.